Compare ORIC & FRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ORIC | FRPH |
|---|---|---|
| Founded | 2014 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 861.3M | 420.6M |
| IPO Year | 2020 | 1995 |
| Metric | ORIC | FRPH |
|---|---|---|
| Price | $10.48 | $23.83 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $19.73 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 57.5K |
| Earning Date | 05-05-2026 | 04-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 19.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $42,846,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 2.57 |
| 52 Week Low | $7.23 | $20.53 |
| 52 Week High | $14.93 | $27.50 |
| Indicator | ORIC | FRPH |
|---|---|---|
| Relative Strength Index (RSI) | 55.01 | 46.39 |
| Support Level | $9.82 | $23.03 |
| Resistance Level | $12.58 | $24.53 |
| Average True Range (ATR) | 0.71 | 0.55 |
| MACD | -0.06 | -0.15 |
| Stochastic Oscillator | 23.34 | 15.96 |
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, industrial, and office (the Development Segment), and (iv) management of mixed-use residential/retail properties owned through joint ventures.